trifluoperazine has been researched along with African Lymphoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bakalova, R | 1 |
| Ohba, H | 1 |
| Zhelev, Z | 1 |
| Kubo, T | 1 |
| Fujii, M | 1 |
| Ishikawa, M | 1 |
| Shinohara, Y | 1 |
| Baba, Y | 1 |
| Daibata, M | 1 |
| Humphreys, RE | 1 |
| Takada, K | 1 |
| Sairenji, T | 1 |
2 other studies available for trifluoperazine and African Lymphoma
| Article | Year |
|---|---|
Atypical protein-kinase Czeta, but neither conventional Ca2+ -dependent protein-kinase C isoenzymes nor Ca2+ -calmodulin, participates in regulation of telomerase activity in Burkitt's lymphoma cells.
Topics: Apoptosis; Burkitt Lymphoma; Calmodulin; Dopamine Antagonists; Enzyme Activation; Flow Cytometry; Fl | 2004 |
Activation of latent EBV via anti-IgG-triggered, second messenger pathways in the Burkitt's lymphoma cell line Akata.
Topics: Alkaloids; Antibodies, Anti-Idiotypic; B-Lymphocytes; Burkitt Lymphoma; Calcimycin; Cyclic AMP; Digl | 1990 |